Ridaura Capsule
Product Images NDC 54766-093

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ridaura (NDC 54766-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca09306001 Ridaura 3mg

This is a description of a pharmaceutical product named "Ridaura", which comes in the form of capsules containing Auranofin. The product is meant to be taken orally and is available in two different doses i.e., 3 mg twice a day or 6 mg once a day as prescribed by the physician. Safety closures must be used when dispensing this product. The product comes in a blue color container and must be stored at a temperature between 15°C and 30°C. For further information, the user should read the accompanying prescribing information or contact the manufacturer.*

FDA Label Image

Lb09306001

This is a medication called auranofin, with a usual adult dosage of 3 mg twice daily or 6 mg once daily, and it is stored between 15°-30°C (59°-86°F). The medication comes in capsules and should be dispensed in a tight, light-resistant container with safety closures. It is distributed by Sebela Pharmaceuticals Inc. For more information, see the accompanying prescribing information.*

FDA Label Image

Chemical Structure (Rid01 0003 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.